This is Psychedellux – the week’s top business headlines for the psychedelics industry.
Field Trip Health Ltd. (OTCQX: FTRPF) has received final approval from The NASDAQ Stock Market to list its common shares on the NASDAQ Global Select Market. The Company’s shares will begin trading at market open on Thursday, July 29, 2021 with the ticker symbol FTRP.
Awakn Life Sciences Corp. (NEO: AWKN) (OTC Pink: AWKNF), a biotechnology company with clinical operations developing and delivering psychedelic medicines to better treat addiction, today announced approval from the Financial Regulatory Authority for its shares to commence trading on the OTC Market in the United States under the symbol “AWKNF” effective today, July 26, 2021. Awakn will continue to trade on the NEO Exchange under its existing symbol “AWKN”.
Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) announced the pricing of its previously announced overnight marketed offering that raised total gross proceeds of $30 million. The company also received approval for the listing of its common shares on the NYSE. Cybin expects its common shares will open for trading on the NYSE on or about August 5, 2021, under the symbol “CYBN”.